ask="43.22"
ask_size="700"
average_daily_volume="1868420"
bid="24.45"
bid_size="100"
book_value="11.83"
change="+0.06"
change_from_200_day_moving_average="-14.68"
change_from_50_day_moving_average="-1.43"
change_from_52_week_high="-48.58"
change_From_52_week_low="9.97"
change_in_percent="+0.15%"
close="41.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.80"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70883000"
high="41.73"
high_52_weeks="89.93"
last_trade_date="1/5/2017"
last_trade_price="41.35"
last_trade_size="50008"
last_trade_time="4:00pm"
low="40.38"
low_52_weeks="31.38"
market_capitalization="3.55B"
moving_average_200_day="56.03"
moving_average_50_day="42.78"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="61.36"
open="41.55"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="-26.20%"
percent_change_from_50_day_moving_average="-3.34%"
percent_change_from_52_week_high="-54.02%"
percent_change_from_52_week_low="+31.77%"
previous_close="41.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.49"
price_per_sales="95.10"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.52"
stock_exchange="NMS"
symbol="ALNY"
volume="573196"
weeks_range_52="31.38 - 89.93"
